Prohance and Scar - a phase IV clinical study of FDA data

Summary:

Scar is reported as a side effect among people who take Prohance (gadoteridol), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Magnevist, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Scar when taking Prohance. It is created by eHealthMe based on reports of 3,733 people who have side effects when taking Prohance from the FDA, and is updated regularly.

What is Prohance?

Prohance has active ingredients of gadoteridol. eHealthMe is studying from 3,734 Prohance users. Check the latest studies of Prohance.

What is Scar?

Scar is found to be associated with 1,251 drugs and 1,423 conditions by eHealthMe. Check the latest studies of Scar.

On Apr, 08, 2026

3,733 people reported to have side effects when taking Prohance.
Among them, 628 people (16.82%) have Scar.

Among these 628 people:

* Approximation only. Some reports may have incomplete information.

Do you take Prohance and have Scar?

- Check whether Scar is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prohance:

Prohance (3,734 reports)

Scar treatments and more:

Scar (24,198 reports)

How severe was Scar and when was it recovered:

Scar in Prohance

Expand to all the drugs that have ingredients of gadoteridol:

Scar and drugs with ingredients of gadoteridol

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prohance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scar:

Scar (1,251 drugs)

Browse all the conditions that are associated with Scar:

Scar (1,423 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadoteridol (the active ingredients of Prohance) and Prohance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.